Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2007 Oct 17;2007(4):CD005454.
doi: 10.1002/14651858.CD005454.pub2.

Antidepressants for neuropathic pain

T Saarto  1 , P J Wiffen
Affiliations
Meta-Analysis

Antidepressants for neuropathic pain

T Saarto et al. Cochrane Database Syst Rev. .

Abstract

Background: This is an updated version of the original Cochrane review published in Issue 3, 2005 of The Cochrane Library. For many years antidepressant drugs have been used to manage neuropathic pain, and are often the first choice treatment. It is not clear, however, which antidepressant is more effective, what role the newer antidepressants can play in treating neuropathic pain, and what adverse effects are experienced by patients.

Objectives: To determine the analgesic effectiveness and safety of antidepressant drugs in neuropathic pain.

Search strategy: Randomised controlled trials (RCTs) of antidepressants in neuropathic pain were identified in MEDLINE (1966 to Oct 2005); EMBASE (1980 to Oct 2005); the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, Issue 3, 2005; and the Cochrane Pain, Palliative and Supportive Care Trials Register (May 2002). Additional reports were identified from the reference list of the retrieved papers, and by contacting investigators.

Selection criteria: RCTs reporting the analgesic effects of antidepressant drugs in adult patients, with subjective assessment of pain of neuropathic origin. Studies that included patients with chronic headache and migraine were excluded.

Data collection and analysis: Two review authors agreed the included studies, extracted data, and assessed methodological quality independently. Sixty one trials of 20 antidepressants were considered eligible (3293 participants) for inclusion. Relative Risk (RR) and Number-Needed-to-Treat (NNTs) were calculated from dichotomous data for effectiveness and adverse effects. This update includes 11 additional studies (778 participants).

Main results: Sixty one RCTs were included in total. Tricyclic antidepressants (TCAs) are effective and have an NNT of 3.6 (95% CI 3 to 4.5) RR 2.1 (95% CI 1.8 to 2.5) for the achievement of at least moderate pain relief. There is limited evidence for the effectiveness of the newer SSRIs but no studies of SNRIs were found. Venlafaxine (three studies) has an NNT of 3.1 (95% CI 2.2 to 5.1) RR 2.2 (95% CI 1.5 to 3.1). There were insufficient data to assess effectiveness for other antidepressants such as St Johns Wort and L-tryptophan. For diabetic neuropathy the NNT for effectiveness was 1.3 (95% CI 1.2 to 1.5) RR 12.4 (95% CI 5.2 to 29.2) (five studies); for postherpetic neuralgia 2.7 (95% CI 2 to 4.1), RR 2.2 (95% CI 1.6 to 3.1) (four studies). There was evidence that TCAs are not effective in HIV-related neuropathies. The number needed to harm (NNH) for major adverse effects defined as an event leading to withdrawal from a study was 28 (95% CI 17.6 to 68.9) for amitriptyline and 16.2 (95% CI 8 to 436) for venlafaxine. The NNH for minor adverse effects was 6 (95% CI 4.2 to 10.7) for amitriptyline and 9.6 (95% CI 3.5 to 13) for venlafaxine.

Authors' conclusions: This update has provided additional confirmation on the effectiveness of antidepressants for neuropathic pain and has provided new information on another antidepressant - venlafaxine. There is still limited evidence for the role of SSRIs. Whether antidepressants prevent the development of neuropathic pain (pre-emptive use) is still unclear. Both TCAs and venlafaxine have NNTs of approximately three. This means that for approximately every three patients with neuropathic pain who are treated with either of these antidepressants, one will get at least moderate pain relief. There is evidence to suggest that other antidepressants may be effective but numbers of participants are insufficient to calculate robust NNTs. SSRIs are generally better tolerated by patients and more high quality studies are required.

PubMed Disclaimer

Conflict of interest statement

None known

Figures

1.1
1.1. Analysis
Comparison 1 Global improvement ‐ number of patients with moderate pain relief or better, Outcome 1 Amitriptyline versus placebo.
1.2
1.2. Analysis
Comparison 1 Global improvement ‐ number of patients with moderate pain relief or better, Outcome 2 Desipramine vs placebo.
1.3
1.3. Analysis
Comparison 1 Global improvement ‐ number of patients with moderate pain relief or better, Outcome 3 Imipramine vs placebo.
1.4
1.4. Analysis
Comparison 1 Global improvement ‐ number of patients with moderate pain relief or better, Outcome 4 Other antidepressants vs placebo.
1.5
1.5. Analysis
Comparison 1 Global improvement ‐ number of patients with moderate pain relief or better, Outcome 5 Tricyclics versus anticonvulsants.
1.6
1.6. Analysis
Comparison 1 Global improvement ‐ number of patients with moderate pain relief or better, Outcome 6 Venlafaxine vs placebo.
2.1
2.1. Analysis
Comparison 2 Diabetic neuropathy, Outcome 1 Antidepressant vs placebo. Number of patients with moderate pain relief or better.
2.2
2.2. Analysis
Comparison 2 Diabetic neuropathy, Outcome 2 Changes in pain intensity: Desipramine vs placebo.
2.3
2.3. Analysis
Comparison 2 Diabetic neuropathy, Outcome 3 Changes in pain intensity: Amitriptyline vs placebo.
2.4
2.4. Analysis
Comparison 2 Diabetic neuropathy, Outcome 4 Changes in pain intensity: Fluoxetine vs placebo.
3.1
3.1. Analysis
Comparison 3 Postherpetic neuralgia‐ number of patients with moderate pain relief or better, Outcome 1 Antidepressant vs placebo.
4.1
4.1. Analysis
Comparison 4 Central pain‐ number of patients with moderate pain relief or better, Outcome 1 Antidepressant vs placebo.
5.1
5.1. Analysis
Comparison 5 Atypical facial pain‐ number of patients with moderate pain relief or better, Outcome 1 Antidepressant vs placebo.
7.1
7.1. Analysis
Comparison 7 Topical Doxepin, Outcome 1 Mean change scores ‐ doxepin vs placebo.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Biesbroeck 1995 {published data only}
    1. Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh SP, et al. A double‐blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Advance in Therapy 1995;12(2):111‐20. - PubMed
Bowsher 1997 {published data only}
    1. Bowsher D. The effects of pre‐emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double‐blind, placebo‐controlled trial. Journal of Pain and Symptom Management 1997;13(6):327‐31. - PubMed
Brady 1987 {published data only}
    1. Brady JP, Cheatle MD, Ball WA. A trial of L‐tryptophan in chronic pain syndrome. Clinical Journal of Pain 1987;3:39‐43.
Carasso 1979 {published data only}
    1. Carasso RL, Yehuda S, Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. International Journal of Neuroscience 1979;9:191‐4. - PubMed
Cardenas 2002 {published data only}
    1. Cardenas DD, Warms CA, Turner JA, Marshall H, Brooke MM, Loeser JD. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 2002;96:365‐73. - PubMed
Ciaramella 2000 {published data only}
    1. Ciaramella A, Grosso S, Poli P. Fluoxetine versus fluvoxamine for treatment of chronic pain [Fluoxetine versus fluvoxamina nel trattamento del dolore cronico]. Minerva Anestesiologica 2000;66:55‐61. - PubMed
Dallocchio 2000 {published data only}
    1. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs amitriptyline in painful diabetic neuropathy: an open label pilot study. Journal of Pain and Symptom Management 2000;20(4):280‐5. - PubMed
Davidoff 1987 {published data only}
    1. Davidoff G, Guarracini M, Roth E, Sliwa J, Yarkony G. Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double‐blind, placebo‐controlled study. Pain 1987;29(2):151‐61. - PubMed
Feinmann 1984 {published data only}
    1. Feinmann C. Psychogenic facial pain: presentation and treatment. Journal of Psychosomatic Research 1983;27(5):404‐10. - PubMed
    1. Feinmann C, Harris M. Psychogenic facial pain: Part 1 The clinical presentation. British Dental Journal 1984;156:165‐8. - PubMed
    1. Feinmann C, Harris M. Psychogenic facial pain: Part 2 Management and Prognosis. British Dental Journal 1984;156:205‐8. - PubMed
    1. Feinmann C, Harris M, Crawley R. Psychogenic facial pain: presentation and treatment. BMJ 1984;288:436‐8. - PMC - PubMed
Forssell 2004 {published data only}
    1. Forssell H, Tasmuth T, Tenovuo O, Hampf G, Kalso E. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. Journal of Orofacial Pain 2004;18(2):131‐7. - PubMed
Gerson 1977 {published data only}
    1. Gerson GR, Jones RB, Luscombe DK. Studies on the concomitant use of carbamazepine and clomipramine for the relief of post‐herpetic neuralgia. Postgraduate Medical Journal 1977;53 Suppl 4:104‐9. - PubMed
Göbel 1997 {published data only}
    1. Göbel H, Stadler TH. Treatment of post‐herpes zoster pain with tramadol [Traitement des doulers post‐zostériennes par le tramodol]. Drugs 1997;53 Suppl 2:34‐9. - PubMed
Gomez‐Perez 1985 {published data only}
    1. Gomez‐Perez FJ, Rull JA, Dies H, Rodriquez‐Rivera JG, Gonzalez‐Barranco J, Lozano‐Castañeda O. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double blind cross over study. Pain 1985;23:395‐400. - PubMed
Gomez‐Perez 1996 {published data only}
    1. Gomez Perez FJ, Choza R, Rios JM, et al. Nortriptyline‐fluphenazine versus carbamazepine in the symptomatic treatment of diabetic neuropathy. Archives of Medical Research 1996;27(4):525‐9. - PubMed
Graff‐Radford 2000 {published data only}
    1. Graff‐Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. The Clinical Journal of Pain 2000;16:188‐92. - PubMed
Hampf 1989 {published data only}
    1. Hampf G, Bowsher D, Nurmikko T. Distigmine and amitriptyline in the treatment of chronic pain. Anesthesia Progress 1989;36(2):58‐62. - PMC - PubMed
Harrison 1997 {published data only}
    1. Harrison SD, Glover L, Feinmann C, Pearce SA, Harris M. A comparison of antidepressant medication alone and in conjunction with cognitive behavioural therapy for chronic idiopathic facial pain. Proceedings of the 8th world congress on pain ‐ Progress in pain research and management. Seattle: IASP Press, 1997; Vol. 8:663‐72.
Kalso 1996 {published data only}
    1. Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1996;64(2):293‐302. - PubMed
Kieburtz 1998 {published data only}
    1. Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology 1998;51(6):1682‐8. - PubMed
Kishore‐Kumar 1990 {published data only}
    1. Kishore‐Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics 1990;47:305‐12. - PubMed
Kvinesdal 1984 {published data only}
    1. Kvinesdal B, Molin D, Froland A, Gram LA. Imipramine therapy of painful diabetic neuropathy. Journal of the American Medical Association 1984;251:1727‐30. - PubMed
    1. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine in the treatment of painful diabetic neuropathy of the extremities [Imipramin ved behandling af smerter ved diabetisk ekstemitetsneuropati]. Ugeskrift for Laeger 1983;145(39):3018‐9. - PubMed
Lampl 2002 {published data only}
    1. Lampl C, Yazdi K, Roper C. Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo‐controlled, long‐term study. Stroke 2002;33(12):3030‐2. - PubMed
Langohr 1982 {published data only}
    1. Langohr HD, Stöhr M, Petruch F. An open and double blind cross over study on the efficacy of Clomipramine (Anafranil) in patients with painful mono‐ and polyneuropathies. European Neurology 1982;21:309‐17. - PubMed
Lascelles 1966 {published data only}
    1. Lascelles RG. Atypical facial pain and depression. British Journal of Psychiatry 1966;112:651‐9. - PubMed
Leijon 1989 {published data only}
    1. Leijon G, Boivie J. Central post‐stroke pain‐a controlled trial of amitriptyline and carbamazepine. Pain 1989;36(1):27‐36. - PubMed
Maina 2002 {published data only}
    1. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single‐blind study. Journal of Clinical Psychiatry 2002;63(1):38‐42. - PubMed
Max 1987 {published data only}
    1. Max MB, Culnane M, Schafer S, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589‐96. - PubMed
Max 1988 {published data only}
    1. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427‐32. - PubMed
Max 1991 {published data only}
    1. Max MB, Kishore‐Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain 1991;45:3‐9. - PubMed
Max 1992a {published data only}
    1. Max MB, Lynch SA, Muir J, Shoaf SF, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine 1992;326:1250‐6. - PubMed
Max 1992b {published data only}
    1. Max MB, Lynch SA, Muir J, Shoaf SF, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine 1992;326:1250‐6. - PubMed
McCleane 2000a {published data only}
    1. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double‐blind, placebo‐controlled study. British Journal of Clinical Pharmacology 2000;49(6):574‐9. - PMC - PubMed
McCleane 2000b {published data only}
    1. McCleane GJ. Topical doxepin hydrochloride reduces neuropathic pain: a randomized double‐blind, placebo controlled study. The Pain Clinic 2000;12:47‐50. - PMC - PubMed
Mercadante 2002 {published data only}
    1. Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo‐controlled, double‐blind crossover study. Tumori 2002;88(3):239‐42. - PubMed
Morello 1999 {published data only}
    1. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double‐blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Archives of Internal Medicine 1999;159(16):1931‐7. - PubMed
    1. Rawn T, Papoushek C, Evans MF. Gabapentin or amitriptyline for painful diabetic neuropathy?. Canadian Family Physician 2000;46:2215‐7. - PMC - PubMed
Panerai 1990 {published data only}
    1. Panerai AE, Monza G, Movilia P, Bianchi M, Francucci BM, Tiengo M. A randomized, within‐patient, cross‐over, placebo‐controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurologica Scandanavica 1990;82(1):34‐8. - PubMed
Pilowsky 1982 {published data only}
    1. Pilowsky I, Hallett EC, Bassett DL, Thomas PG, Penhall RK. A controlled study of amitriptyline in the treatment of chronic pain. Pain 1982;14(2):169‐79. - PubMed
Raja 2002 {published data only}
    1. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo‐controlled trial. Neurology 2002;59(7):1015‐21. - PubMed
Reuben 2004 {published data only}
    1. Reuben SS, Makari‐Judson G, Lurie SD. Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. Journal of Pain and Symptom Management 2004;27(2):133‐9. - PubMed
Robinson 2004 {published data only}
    1. Robinson LR, Czerniecki JM, Ehde DM, Edwards WT, Judish DA, Goldberg ML, et al. Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Archives of Physical Medicine and Rehabilitation 2004;85(1):1‐6. - PubMed
Rowbotham 2004 {published data only}
    1. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double blind, placebo‐controlled study. Pain 2004;110:697‐706. - PubMed
Semenchuk 2001 {published data only}
    1. Semenchuk MR, Sherman S, Davis B. Double‐blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 2001;57(9):1583‐8. - PubMed
Sharav 1987 {published data only}
    1. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987;31(2):199‐209. - PubMed
Shlay 1998 {published data only}
    1. Shlay J, Chaloner K, Max M, Flaws B, Reichelderfer P, Wentworth D, et al. Acupuncture and amitriptyline for pain due to HIV‐related peripheral neuropathy. JAMA 1998;280:1590‐5. - PubMed
Simpson 2001 {published data only}
    1. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. Journal of Clinical Neuromuscular Disease 2001;3(2):53‐62. - PubMed
Sindrup 1989 {published data only}
    1. Sindrup SH, Ejlertsen B, Frøland A, Sindrup EH, Brøsen K, Gram LF. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. European Journal of Clinical Pharmacology 1989;37:151‐3. - PubMed
Sindrup 1990a {published data only}
    1. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135‐44. - PubMed
Sindrup 1990b {published data only}
    1. Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck‐Nielsen H. Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology 1990;30:683‐91. - PMC - PubMed
Sindrup 1992a {published data only}
    1. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes‐Jorgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clinical Pharmacology & Therapeutics 1992;52(5):547‐52. - PubMed
Sindrup 1992b {published data only}
    1. Sindrup SH, Tuxen C, Gram LF, et al. Lack of effect of mianserin on the symptoms of diabetic neuropathy. European Journal of Clinical Pharmacology 1992;43:251‐5. - PubMed
Sindrup 2001 {published data only}
    1. Sindrup SH, Madsen C, Bach FW, Gram LF, Jensen TS. St. John's wort has no effect on pain in polyneuropathy. Pain 2001;91(3):361‐5. - PubMed
Sindrup 2003 {published data only}
    1. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003;60(8):1284‐9. - PubMed
Tammiala‐Salonen 99 {published data only}
    1. Tammiala‐Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo‐controlled, double‐blind study. Journal of Orofacial Pain 1999;13(2):83‐8. - PubMed
Tasmuth 2002 {published data only}
    1. Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. European Journal of Pain 2002;6(1):17‐24. - PubMed
Turkington 1980 {published data only}
    1. Turkington RW. Depression masquerading as diabetic neuropathy. JAMA 1980;243:1147‐50. - PubMed
Ventafridda 1987 {published data only}
    1. Ventafridda V, Bonezzi C, Caraceni A, Conno F, Guarise G, Ramella G, et al. Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone. Italian Journal of Neurological Sciences 1987;8(6):579‐87. - PubMed
    1. Ventafridda V, Caraceni A, Saita L, Bonezzi C, Conno F, Guarise G, et al. Trazodone for deafferentation pain. Comparison with amitriptyline. Psychopharmacology 1988;95 Suppl:S44‐9. - PubMed
Vrethem 1997 {published data only}
    1. Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindstrom T, Thorell LH. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clinical Journal of Pain 1997;13(4):313‐23. - PubMed
Watson 1982 {published data only}
    1. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671‐3. - PubMed
Watson 1992 {published data only}
    1. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized,double‐blind, crossover trial. Pain 1992;48(1):29‐36. - PubMed
Watson 1998 {published data only}
    1. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51(4):1166‐71. - PubMed
Yucel 2004 {published data only}
    1. Yucel A, Ozyalcin S, Koknel Talu G, Kiziltan E, Yucel B, Andersen OK, et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. European Journal of Pain 2005;9(4):407‐16. - PubMed

References to studies excluded from this review

Aragona 2005 {published data only}
    1. Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, et al. Randomized double‐blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM‐IV‐TR pain disorder. European Journal of Pain 2005;9(1):33‐8. - PubMed
Aronoff 1982 {published data only}
    1. Aronoff GM, Evans WO. Doxepin as an adjunct in the treatment of chronic pain. Journal of Clinical Psychiatry 1982;43(8 part 2):42‐7. - PubMed
Battla 1981 {published data only}
    1. Battla H, Silverblatt CW. Clinical trial of amitriptyline and fluphenazine in diabetic peripheral neuropathy. Southern Medical Journal 1981;74(4):417‐8. - PubMed
Beaumont 1980 {published data only}
    1. Beaumont G, Seldrup J. Comparative trial of clomipramine and placebo in the treatment of terminal pain. Journal of International Medical Research 1980;8 (supp):37‐9. - PubMed
Blumer 1980 {published data only}
    1. Blumer D, Heilbronn M. Second‐year follow‐up study on systematic treatment of chronic pain with antidepressants. Henry Ford Hospital Medical Journal 1981;29(2):67‐8. - PubMed
Blumer 1981 {published data only}
    1. Brenne E, Hagen K, Maehlum E, Husebo S. Treatment of chronic pain with amitriptyline. A double‐blind dosage study with determination of serum levels. Tidsskrift for den Norske Laegeforening 1997;117:3491‐4. - PubMed
Bogetto 1999 {published data only}
    1. Bogetto F, Bonatto Revello R, Ferro G, Maina G, Ravizza L. Psychopharmacological treatment of burning mouth syndrome [Trattamento psicofarmacologico della Burning Mouth Syndrome]. Minerva Psichiatrica 1999;40:1‐10.
Brenne 1997 {published data only}
    1. Brenne E, Hagen K, Maehlum E, Husebo S. Treatment chronic pain with amitriptyline. A double‐blind dosage study with determination of serum levels [Behandling av pasienter med kroniske smerter med amitriptylin. Dobbeltblind doseringsundersokelse med serumkonsentrasjonsbestemmelse]. Tidsskr Nor Laegeforen 1997;117(24):3491‐4. - PubMed
Davis 1977 {published data only}
    1. Davis JL, Lewis SB, Gerich JE, Kaplan RA, Schultz TA, Wallin JD. Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. JAMA 1977;238(21):2291‐2. - PubMed
Eberhard 1988 {published data only}
    1. Eberhard G, vonKnorring L, Nilsson HL, Sundequist U, Bjorling G, Linder H, et al. A double‐blind randomised study of clomipramine versus maprotiline in patients with idiopathic pain syndromes. Neuropsychobiology 1988;19:25‐34. - PubMed
Edelbroek 1986 {published data only}
    1. Edelbroek PM, Linssen AC, Zitman FG, Rooymans HG, Wolff FA. Analgesic and antidepressive effects of low‐dose amitriptyline in relation to its metabolism in patients with chronic pain. Clinical Pharmacology & Therapeutics 1986;39(2):156‐62. - PubMed
Erzurumlu 1996 {published data only}
    1. Erzurumlu A, Dursun H, Gunduz S, Kalyon TA, Apracioglu O. The management of chronic pain at spinal cord injured patients. The comparison of effectiveness amitryptiline and carbamazepine combination and electroacupuncture application [Spinal Kord Yarali Hastalarda Kronik Agri Tedavisi]. Journal of Rheumatology and Medical Rehabilitation 1996;7(3):176‐80.
Evans 1973 {published data only}
    1. Evans W, Gensler F, Blackwell B, Galbrecht C. The effects of antidepressant drugs on pain relief and mood in the chronically ill. A double blind study. Psychosomatics 1973;14:214‐5. - PubMed
Gade 1980 {published data only}
    1. Gade GN, Hofeldt FD, Treece GL. Diabetic neuropathic cachexia. Beneficial response to combination therapy with amitriptyline and fluphenazine. JAMA 1980;243(11):1160‐1. - PubMed
Gourlay 1986 {published data only}
    1. Gourlay GK, Cherry DA, Cousins MJ, Love BL, Graham JR, McLachlan MO. A controlled study of a serotonin reuptake blocker, zimelidine in the treatment of chronic pain. Pain 1986;25:35‐52. - PubMed
Hameroff 1982 {published data only}
    1. Hameroff SR, Cork RC, Scherer K, Crago BR, Neuman C, Womble JR, et al. Doxepin effects on chronic pain, depression and plasma opioids. Journal of Clinical Psychiatry 1982;43(8 Pt2):22‐7. - PubMed
Hameroff 1984 {published data only}
    1. Hameroff SR, Weiss JL, Lerman JC, Cork RC, Watts KS, Crago BR, et al. Doxepin's effects on chronic pain and depression: a controlled study. Journal of Clinical Psychiatry 1984;45(3 Pt2):47‐53. - PubMed
Hameroff 1985 {published data only}
    1. Hameroff SR, Cork RC, Weiss JL, Crago BR, Davis TP. Doxepin effects on chronic pain and depression a controlled study. The Clinical Journal of Pain 1985;1:171‐6.
Johansson 1979 {published data only}
    1. Johansson F, Knorring L. A double‐blind controlled study of seratonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients. Pain 1979;7(1):69‐78. - PubMed
Jørgensen 1984 {published data only}
    1. Jørgensen B, Nørrelund N, Bech P, Jakobsen K. Pain and depressive symptoms in general practice [Smerter og depressive symptomer i almen praksis]. Ugeskrift for Laeger 1984;146(38):2868‐72. - PubMed
Khurana 1983 {published data only}
    1. Khurana RC. Treatment of painful diabetic neuropathy with trazodone. JAMA 1983;250(11):1392. - PubMed
Kumar 1998 {published data only}
    1. Kumar D, Alvaro MS, Julka IS, Marshall HJ. Diabetic peripheral neuropathy: effectiveness of electrotherapy and amitriptyline for symptomatic relief. Diabetes Care 1998;21(8):1322‐5. - PubMed
Loldrup 1989 {published data only}
    1. Loldrup D, Langemark M, Hansen HJ, Olesen J, Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. Psychopharmacology 1989;99:1‐7. - PubMed
McQuay 1992 {published data only}
    1. McQuay HJ, Carroll D, Glynn CJ. Low dose amitriptyline in the treatment of chronic pain. Anaesthesia 1992;47:646‐52. - PubMed
McQuay 1993 {published data only}
    1. McQuay HJ, Carroll D, Glynn CJ. Dose‐response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993;48(4):281‐5. - PubMed
Mendel 1986 {published data only}
    1. Mendel CM, Klein RF, Chappell DA, Dere WH, Gertz BJ, Karam JH. A trial of amitriptypline and fluphenazine in the treatment of painful diabetic neuropathy. JAMA 1986;255(5):637‐9. - PubMed
Minotti 1998 {published data only}
    1. Minotti V, Angelis V, Righetti E, et al. Double‐blind evaluation of short‐term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain. Pain 1998;74(2):133‐7. - PubMed
Onghena 1993 {published data only}
    1. Onghena P, Cuyper H, Houdenhove B, Verstraeten D. Mianserin and chronic pain: a double‐blind placebo‐controlled process and outcome study. Acta Psychiatrica Scandanavica 1993;88(3):198‐204. - PubMed
Pilowsky 1990 {published data only}
    1. Pilowsky I, Barrow CG. A controlled study of psychotherapy and amitriptyline used individually and in combination in the treatment of chronic intractable, 'psychogenic' pain. Pain 1990;40(1):3‐19. - PubMed
Pilowsky 1995 {published data only}
    1. Pilowsky I, Spence N, Rounsefell B, Forsten C, Soda J. Out‐patient cognitive‐behavioural therapy with amitriptyline for chronic non‐malignant pain: a comparative study with 6‐month follow‐up. Pain 1995;60(1):49‐54. - PubMed
Plesh 2000 {published data only}
    1. Plesh O, Curtis D, Levine J, McCall Jnr D. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. Journal of Oral Rehabilitation 2000;27:834‐41. - PubMed
Raftery 1979 {published data only}
    1. Raftery H. The management of post herpetic pain using sodium valproate and amitriptyline. Journal of the Irish Medical Association 1979;72(9):399‐401. - PubMed
Rawn 2000 {published data only}
    1. Rawn T, Papoushek C, Evans MF. Gabapentin or amitriptyline for painful diabetic neuropathy?. Canadian Family Physician 2000;46:2215‐7. - PMC - PubMed
Semenchuk 2000 {published data only}
    1. Semenchuk MR, Davis B. Efficacy of sustained‐release bupropion neuropathic pain: An open‐label study. The Clinical Journal of Pain 2000;16:6‐11. - PubMed
Sindrup 1990c {published data only}
    1. Sindrup SH, Gram LF, Skjold T, Frøland A, Beck‐Nielsen H. Concentration‐ response relationship in imipramine treatment of diabetic neuropathy symptoms. Clinical Pharmacology and Therapeutics 1990;47(4):509‐15. - PubMed
Sindrup 1991 {published data only}
    1. Sindrup SH, Grodum E, Gram LF, Beck‐Nielsen H. Concentration‐response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient‐blinded dose‐escalation study. Therapeutic Drug Monitoring 1991;13(5):408‐14. - PubMed
Sindrup 1992c {published data only}
    1. Sindrup SH, Bach FW, Gram LF. Plasma beta‐endorphin is not affected by treatment with imipramine or paroxetine in patients with diabetic neuropathy symptoms. Clinical Journal of Pain 1992;8(2):145‐8. - PubMed
Standford 1992 {published data only}
    1. Sandford PR, Lindblom LB, Haddox JD. Amitriptyline and carbamazepine in the treatment of dysesthetic pain in spinal cord injury. Archives of Physical Medicine and Rehabilitation 1992;73(3):300‐1. - PubMed
Stockstill 1989 {published data only}
    1. Stockstill JW, McCall WD, Gross AJ, Piniewski B. The effect of L‐tryptophan supplementation and dietary instruction on chronic myofascial pain. Journal of the American Dental Association 1989;118(4):457‐60. - PubMed
Takeda 1988 {published data only}
    1. Takeda Y, Kobayashi H, Suzuki K, Sei Y, Nishio K, Ishizaki H. Analgesic effects of clomipramine (Anafranil) on postherpetic neuralgia. Skin Research 1988;30:33‐6.
Van Houdenhove 1992 {published data only}
    1. Houdenhove B, Verstraeten D, Onghena P, DeCuyper H. Chronic idiopathic pain, minanserin and 'masked depression'. Psychotherapy and Pyschosomatics 1992;58:45‐53. - PubMed
Van Kempen 1992 {published data only}
    1. Kempen GMJ, Zitman FG, Linssen ACG, Edelbroek PM. Biochemical measures in patients with a somatoform pain disorder, before, during and after treatment with amitriptyline with or without fulpentixol. Biological Psychiatry 1992;31:670‐80. - PubMed
Vidal 2004 {published data only}
    1. Vidal M, Martinez‐Fernandez E, Martinez‐ Vazquez de Castro J, et al. Effectiveness of gabapentine and amitriptyline in the diabetic neuropathy pain. Revista de la Sociedad Espanola del Dolor 2004;11(5):292‐305.
von Knorring 1979 {published data only}
    1. Knorring L, Johansson F. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine versus placebo in chronic pain patients. Psychiatry Research 1979;1(31):225‐30. - PubMed
von Knorring 1980 {published data only}
    1. Knorring L, Johansson F. Changes in the augmenter‐reducer tendency and in pain measures as a result of treatment with a serotonin‐reuptake‐inhibitor ‐ Zimelidine. Neuropsychobiology 1980;6:313‐8. - PubMed
Watson 1985 {published data only}
    1. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in post‐herpetic neuralgia. Pain 1985;23:387‐94. - PubMed
Young 1985 {published data only}
    1. Young RJ, Clarke BF. Pain relief in diabetic neuropathy: The effectiveness of imipramine and related drugs. Diabetic Medicine 1985;2:363‐6. - PubMed
Zitman 1990 {published data only}
    1. Zitman FG, Linssen ACG, Edelbrock PM, Stijnen T. Low dose amitriptyline in chronic pain: the gain is modest. Pain 1990;42:35‐42. - PubMed
Zitman 1991 {published data only}
    1. Zitman FG, Linssen AC, Edelbroek PM, Kempen GM. Does addition of low‐dose flupentixol enhance the analgetic effects of low‐dose amitriptyline in somatoform pain disorder?. Pain 1991;47(1):25‐30. - PubMed

References to studies awaiting assessment

Paladini 1987 {published data only}
    1. Paladini VA, Batiigelli D, Antonaglia V, Benvegnu M, Longo A, et al. Doxepin in pain caused by peripheral neuropathy [La doxopine nel dolore da neuropatia periferica]. Minerva Anestesiol 1987;53:413‐8. - PubMed

Additional references

BNF 2006
    1. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary Number 51. http://www.bnf.org March 2006.
Collins 2000
    1. Collins SL, Moore RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. Journal of Pain and Symptom Management 2000;20(6):449‐58. - PubMed
Cook 1995
    1. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452‐4. - PMC - PubMed
Feighner 1999
    1. Feighner JP. Mechanism of action of antidepressant medications. Journal of Clinical Psychiatry 1999;60(Suppl 4):4‐11. - PubMed
Glassman 1993
    1. Glassman AH, Preud'homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. Journal of Clinical Psychiatry 1993;54(Suppl):16‐22. - PubMed
Glassman 1998
    1. Glassman AH. Cardiovascular effects of antidepressant drugs: updated. Journal of Clinical Psychiatry 1998;59(Suppl 15):13‐8. - PubMed
Higgins 2006
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library. John Wiley & Sons: Chichester, UK, Issue 4, 2006.
Jackson 2004
    1. Jackson JL, Berbano EP, DeZee KJ, Diemer MM, Mikita JA, O'Malley PG, et al. Tricyclic antidepressants for the prevention of migraine and tension‐type headache. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD005036.] - DOI
Jadad 1996
    1. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1‐12. - PubMed
Magni 1991
    1. Magni G. The use of antidepressants in the treatment of chronic pain: a review of the current evidence. Drugs 1991;42:730‐48. - PubMed
Martindale 2004
    1. Martindale. The Complete Drug Reference. 4th Edition. London: Pharmaceutical Press, 2004.
Max 1995
    1. Max MB. Thirteen consecutive well‐designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum 1995;4:348‐53.
McCleane 2003
    1. McCleane G. Pharmacological management of neuropathic pain. CNS Drugs 2003;14(14):1031‐43. - PubMed
McQuay 1995
    1. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311:1047‐52. - PMC - PubMed
McQuay 2007
    1. McQuay HJ, Smith LA, Moore RA. Chronic pain. Health Needs Assessment. Oxford: Radcliffe Publishing Ltd, 2007:519‐99.
MIMS 2002
    1. Anon. Monthly Index of Medical Specialities. London: Haymarket Medical Publications, May 2002.
Moore 1998
    1. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything‐large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209‐16. - PubMed
Onghena 1992
    1. Onghena P, Houdenhove B. Antidepressant‐induced analgesia in chronic non‐malignant pain: a meta‐analysis of 39 placebo‐controlled studies. Pain 1992;49:205‐20. - PubMed
Peretti 2000
    1. Peretti S, Judge R, Hindmarch I. Safety and tolerability considerations: tricyclic antidepressants versus selective serotonine reuptake inhibitors. Acta Psychiatrica Scandanavica 2000;403(Suppl):17‐25. - PubMed
Tremont‐Lukats 2000
    1. Tremont‐Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes. Drugs 2000;60(5):1029‐52. - PubMed
Wiffen 2001
    1. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore RA. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001133.pub2] - DOI
Woolf 1999
    1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959‐64. - PubMed

References to other published versions of this review

McQuay 1996
    1. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217‐27. - PubMed

MeSH terms